Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines
Public ClinicalTrials.gov record NCT04631588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1b Safety and Tolerability of Intradermal BOTOX® (OnabotulinumtoxinA) Purified Neurotoxin Complex in Participants With Facial Fine Lines
Study identification
- NCT ID
- NCT04631588
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 172 participants
Conditions and interventions
Conditions
Interventions
- Botox Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 15, 2020
- Primary completion
- Nov 2, 2021
- Completion
- Nov 2, 2021
- Last update posted
- Nov 15, 2021
2020 – 2021
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Skin and Cancer Associates, LLP /ID# 225152 | Miami | Florida | 33137-3254 | — |
| Laser & Skin Surgery Center of New York /ID# 225153 | New York | New York | 10016-4974 | — |
| Tennessee Clinical Research Center /ID# 225151 | Nashville | Tennessee | 37215-2885 | — |
| Austin Institute for Clinical Research /ID# 225154 | Pflugerville | Texas | 78660 | — |
| Advanced Clinical Research /ID# 225155 | Salt Lake City | Utah | 84101-1345 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04631588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04631588 live on ClinicalTrials.gov.